TFRC and breast carcinoma: It directly binds to TfR1, causing iron deprivation and ROS imbalance with degradations of several oncoproteins, especially FGFR1, through the proteasome pathway, thereby promoting cell apoptosis in MDA-MB-231 breast cancer cells.